BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 8806693)

  • 1. Transactivation of the GATA-1 promoter by a myb-ets-containing mouse retrovirus is mediated by CACCC elements.
    Sun-Hoffman L; Aurigemma RE; Sun B; Ruscetti SK
    Oncogene; 1996 Sep; 13(5):1037-42. PubMed ID: 8806693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The GATA-1 and Spi-1 transcriptional factors bind to a GATA/EBS dual element in the Fli-1 exon 1.
    Barbeau B; Barat C; Bergeron D; Rassart E
    Oncogene; 1999 Sep; 18(40):5535-45. PubMed ID: 10523830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody.
    Seth A; Robinson L; Thompson DM; Watson DK; Papas TS
    Oncogene; 1993 Jul; 8(7):1783-90. PubMed ID: 8510925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GATA-and SP1-binding sites are required for the full activity of the tissue-specific promoter of the tal-1 gene.
    Lecointe N; Bernard O; Naert K; Joulin V; Larsen CJ; Romeo PH; Mathieu-Mahul D
    Oncogene; 1994 Sep; 9(9):2623-32. PubMed ID: 8058326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transactivation of erythroid transcription factor GATA-1 by a myb-ets-containing retrovirus.
    Aurigemma RE; Blair DG; Ruscetti SK
    J Virol; 1992 May; 66(5):3056-61. PubMed ID: 1560536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-MYB transactivates its own promoter through SP1-binding sites.
    Sala A; Saitta B; De Luca P; Cervellera MN; Casella I; Lewis RE; Watson R; Peschle C
    Oncogene; 1999 Feb; 18(6):1333-9. PubMed ID: 10022815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of Sp1/Sp3 in the activation of the GATA-1 erythroid promoter in K562 cells.
    Hou CH; Huang J; He QY; Zhang CN; Zhang XJ; Qian RL
    Cell Res; 2008 Feb; 18(2):302-10. PubMed ID: 18195733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GATA-1 and c-myb crosstalk during red blood cell differentiation through GATA-1 binding sites in the c-myb promoter.
    Bartůnek P; Králová J; Blendinger G; Dvorák M; Zenke M
    Oncogene; 2003 Apr; 22(13):1927-35. PubMed ID: 12673198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of the human A-myb promoter: regulation by NF-Y and Sp1.
    Facchinetti V; Lopa R; Spreafico F; Bolognese F; Mantovani R; Tavner F; Watson R; Introna M; Golay J
    Oncogene; 2000 Aug; 19(34):3931-40. PubMed ID: 10951586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional regulation in megakaryocytes: the thrombopoietin receptor gene as a model.
    Mignotte V; Deveaux S; Filipe A
    Stem Cells; 1996; 14 Suppl 1():232-9. PubMed ID: 11012226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transcription of the intercellular adhesion molecule-1 is regulated by Ets transcription factors.
    de Launoit Y; Audette M; Pelczar H; Plaza S; Baert JL
    Oncogene; 1998 Apr; 16(16):2065-73. PubMed ID: 9572487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of DNA binding activity of the GATA-1 transcription factor in the apoptotic process induced by overexpression of PU.1 in murine erythroleukemia cells.
    Yamada T; Kihara-Negishi F; Yamamoto H; Yamamoto M; Hashimoto Y; Oikawa T
    Exp Cell Res; 1998 Nov; 245(1):186-94. PubMed ID: 9828115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
    Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K
    Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
    Lennartsson A; Garwicz D; Lindmark A; Gullberg U
    Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TATA-box dependent trans-activation of the human HSP70 promoter by Myb proteins.
    Foos G; Natour S; Klempnauer KH
    Oncogene; 1993 Jul; 8(7):1775-82. PubMed ID: 8510924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic activation of the TATA-less mouse thymidylate synthase promoter by the Ets transcription factor GABP and Sp1.
    Rudge TL; Johnson LF
    Exp Cell Res; 2002 Mar; 274(1):45-55. PubMed ID: 11855856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M; Boss GR; Pascual FE; Pilz RB
    Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythroid regulatory elements.
    Raich N; Romeo PH
    Stem Cells; 1993 Mar; 11(2):95-104. PubMed ID: 8096156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E2F and GATA-1 are required for the Sertoli cell-specific promoter activity of the follicle-stimulating hormone receptor gene.
    Kim JS; Griswold MD
    J Androl; 2001; 22(4):629-39. PubMed ID: 11451360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The v-Rel oncoprotein increases expression from Sp1 site-containing promoters in chicken embryo fibroblasts.
    Sif S; Capobianco AJ; Gilmore TD
    Oncogene; 1993 Sep; 8(9):2501-9. PubMed ID: 8361761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.